Lotus Eye Hospital & Institute Downgraded to 'Sell' by MarketsMOJO, Caution for Investors

Sep 02 2024 06:56 PM IST
share
Share Via
Lotus Eye Hospital & Institute, a microcap company in the healthcare services industry, has been downgraded to a 'Sell' by MarketsMojo due to its flat results and expensive valuation. The stock has underperformed the market and promoter confidence has decreased. While the company has a strong financial position, its technical trend is currently sideways. Investors should exercise caution before investing in this stock.
Lotus Eye Hospital & Institute, a microcap company in the healthcare services industry, has recently been downgraded to a 'Sell' by MarketsMOJO on September 2, 2024. This decision was based on the company's flat results in June 2024, with a decrease of -58.93% in its PAT (9M) at Rs 1.31 crore. Additionally, the company's ROE of 3.6 and expensive valuation with a 2.7 Price to Book Value suggest that the stock is trading at a premium compared to its historical valuations.

Moreover, the stock has underperformed the market in the last year, generating negative returns of -13.94% while the market (BSE 500) has seen a return of 38.49%. This decline in profits may also be attributed to the decrease in promoter confidence, as they have reduced their stake in the company by -1.16% over the previous quarter and currently hold 40.24% of the company. This could be seen as a sign of reduced confidence in the future of the business.

In addition, the company has a low Debt to Equity ratio (avg) at 0 times, indicating a strong financial position. However, the technical trend for the stock is currently sideways, with no clear price momentum. The trend has deteriorated from Mildly Bullish on September 2, 2024, and has generated a return of 3.9% since then.

Overall, the downgrade to 'Sell' by MarketsMOJO and the company's recent performance suggest caution for investors considering Lotus Eye Hospital & Institute. It is important to carefully evaluate all factors before making any investment decisions.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
Kamdhenu Ventures Ltd is Rated Sell
28 minutes ago
share
Share Via
Ircon International Ltd is Rated Strong Sell
28 minutes ago
share
Share Via
BMW Industries Ltd is Rated Sell
28 minutes ago
share
Share Via
Veritas (India) Ltd is Rated Strong Sell
28 minutes ago
share
Share Via
Last Mile Enterprises Ltd is Rated Sell
28 minutes ago
share
Share Via
Aveer Foods Ltd is Rated Sell
28 minutes ago
share
Share Via